Johns Hopkins Joins Cancer AI Alliance
Johns Hopkins MedicineHarnessing the power of artificial intelligence (AI) will enable new strategies for tackling cancer in a collaborative venture that brings together team science and vast data resources.
Harnessing the power of artificial intelligence (AI) will enable new strategies for tackling cancer in a collaborative venture that brings together team science and vast data resources.
James and Heather Gills have donated $10 million to the Wilmer Eye Institute, Johns Hopkins Medicine, for establishment of a new center at Wilmer: the James P. Gills Jr., M.D., & Heather Gills Artificial Intelligence Innovation Center.
By studying rare fossils of jaws and other skull parts of a long-extinct Caribbean monkey, a team of researchers that includes a Johns Hopkins University School of Medicine professor says it has uncovered new evidence documenting the anatomy and ecology of an extinct primate once found on Hispaniola 鈥 the Caribbean island on which Haiti and the Dominican Republic are located.
In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic version of marijuana鈥檚 main ingredient, THC, reduces agitation in patients with Alzheimer鈥檚 by an average of 30%.
Using a sophisticated brain-imaging system, neuroscientists at Johns Hopkins Medicine say they have successfully reactivated a specific memory circuit in mice, causing them to seek out shelter when no shelter is actually present.
About 3,700 babies died suddenly and unexpectedly in the United States in 2022, according to the Centers for Disease Control and Prevention. More than one out of three of those deaths wer due to sudden infant death syndrome (SIDS) 鈥 the unexplained death of a healthy baby less than 1 year old.
A blood test that uses artificial intelligence (AI) to detect cancer-related genetic changes and protein biomarkers could help screen women for early signs of ovarian cancer, according to a study by researchers at the聽Johns Hopkins Kimmel Cancer Center in collaboration with several other institutions in the United States and Europe.
Researchers at the Johns Hopkins University School of Medicine have mapped variation in human stem cells that explains how cells of an individual may shape a unique 鈥渄evelopmental dance鈥 at the molecular level, thereby controlling how the brain and body are created.
In a review of previous studies, a Johns Hopkins Children鈥檚 Center team concludes that some video games created as mental health interventions can be helpful 鈥 if modest 鈥 tools in improving the mental well-being of children and teens with anxiety, depression and attention-deficit/hyperactivity disorder (ADHD).
Johns Hopkins Medicine scientists who arranged for 48 human bioengineered heart tissue samples to spend 30 days at the International Space Station report evidence that the low gravity conditions in space weakened the tissues and disrupted their normal rhythmic beats when compared to earth-bound samples from the same source.
By tracking the changes in prostate cancer cells over time, researchers at the Johns Hopkins Kimmel Cancer Center have found that activation of the MYC gene 鈥 a well-known cancer-causing gene 鈥 sets off a cascade of events that leads to both initiation and progression of the disease.
September is National Sickle Cell Awareness Month. Experts from Johns Hopkins Medicine who specialize in sickle cell disease are available to discuss health equity issues related to sickle cell disease.
Nadia Hansel, M.D., a pulmonary and critical care physician and expert in the environmental determinants of obstructive lung diseases, has been named director of the Department of Medicine at the Johns Hopkins University School of Medicine and physician-in-chief of The Johns Hopkins Hospital. Hansel is the William Osler Professor of Medicine. She is the first woman to lead the storied Department of Medicine in its 131-year history.
Brenda Banwell, M.D., has been named pediatrician-in-chief and co-director of Johns Hopkins Children鈥檚 Center. She also serves as director of the Department of Pediatrics at the Johns Hopkins University School of Medicine. Banwell began in the position on Sept. 1, 2024.
People with operable non-small cell lung cancers may fare better over the next few years by receiving immunotherapy treatments before and after surgery instead of only before surgery, according to a new analysis by Johns Hopkins Kimmel Cancer Center investigators.
Age-related changes in the fibroblasts, cells that create the skin鈥檚 structure, contribute to the development of aggressive, treatment-resistant melanoma in males, according to research in mice by the Johns Hopkins Kimmel Cancer Center.
In a study using human breast cancer cells, scientists say they have potentially identified immune system white blood cells that appear to be the closest neighbors of breast cancer cells that are likely to spread.
Using a new workflow that integrates spatial transcriptomics and machine learning for imaging analysis and integration with single-cell datasets, researchers at the Johns Hopkins Kimmel Cancer Center have identified novel molecular and cellular markers in the development of one of the most aggressive, deadly pancreatic cancers: pancreatic ductal adenocarcinoma (PDAC).
The anti-cancer drug olaparib may be effective in treating biochemically recurrent prostate cancer without accompanying hormone therapy for men who have mutations in genes such as BRCA2, according to results of a phase II clinical trial of 51 patients conducted at the Johns Hopkins Kimmel Cancer Center and three other sites.聽
A novel test developed by Johns Hopkins Kimmel Cancer Center investigators could give gastroenterologists insight into which patients with Barrett鈥檚 esophagus 鈥 a premalignant condition in which parts of the esophagus become damaged by chronic acid reflux 鈥 are likely to progress to esophageal cancer or an abnormal collection of cells called high-grade dysplasia.